PL2234607T3 - Preparat o przedłużonym uwalnianiu oparty na połączeniu glikogenu i alginianu - Google Patents

Preparat o przedłużonym uwalnianiu oparty na połączeniu glikogenu i alginianu

Info

Publication number
PL2234607T3
PL2234607T3 PL08867925T PL08867925T PL2234607T3 PL 2234607 T3 PL2234607 T3 PL 2234607T3 PL 08867925 T PL08867925 T PL 08867925T PL 08867925 T PL08867925 T PL 08867925T PL 2234607 T3 PL2234607 T3 PL 2234607T3
Authority
PL
Poland
Prior art keywords
glycogen
alginate
association
slow
release formulation
Prior art date
Application number
PL08867925T
Other languages
English (en)
Inventor
Vincenzo Russo
Elisa Liberati
Nicola Cazzolla
Leonardo Marchitto
Lorella Ragni
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of PL2234607T3 publication Critical patent/PL2234607T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL08867925T 2007-12-28 2008-12-23 Preparat o przedłużonym uwalnianiu oparty na połączeniu glikogenu i alginianu PL2234607T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07425828 2007-12-28
EP08867925A EP2234607B1 (en) 2007-12-28 2008-12-23 A slow-release formulation based on an association of glycogen and alginate
PCT/EP2008/068256 WO2009083561A1 (en) 2007-12-28 2008-12-23 A slow-release formulation based on an association of glycogen and alginate

Publications (1)

Publication Number Publication Date
PL2234607T3 true PL2234607T3 (pl) 2011-12-30

Family

ID=39522216

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08867925T PL2234607T3 (pl) 2007-12-28 2008-12-23 Preparat o przedłużonym uwalnianiu oparty na połączeniu glikogenu i alginianu

Country Status (21)

Country Link
US (1) US8840923B2 (pl)
EP (1) EP2234607B1 (pl)
JP (1) JP5416716B2 (pl)
KR (1) KR101561571B1 (pl)
CN (1) CN101909608B (pl)
AR (1) AR069960A1 (pl)
AT (1) ATE518530T1 (pl)
AU (1) AU2008342571B2 (pl)
BR (1) BRPI0821454B8 (pl)
CA (1) CA2708400C (pl)
DK (1) DK2234607T3 (pl)
EA (1) EA018975B1 (pl)
ES (1) ES2369868T3 (pl)
GE (1) GEP20125636B (pl)
HK (1) HK1145284A1 (pl)
IL (1) IL206124A (pl)
PL (1) PL2234607T3 (pl)
PT (1) PT2234607E (pl)
SI (1) SI2234607T1 (pl)
UA (1) UA98684C2 (pl)
WO (1) WO2009083561A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1006902A2 (pt) 2009-01-23 2016-02-16 Aziende Chimiche Riunte Angelini Francesco A C R A F S P A formulação farmacêutica ou alimentícia de liberação controlada, processo para a produção de uma forma farmacêutica ou alimentícia, sistema de liberação controlada, e, uso de um sistema de liberação controlada
WO2011015509A1 (en) * 2009-08-03 2011-02-10 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Food formulation comprising glycogen
CN105491994A (zh) 2013-04-26 2016-04-13 奇迹连结生物技术公司 单分散性糖原和植物糖原纳米颗粒及其作为化妆品、药品、和食品产品中的添加剂的用途
CN106137977B (zh) * 2015-04-28 2019-12-13 浙江普利药业有限公司 海参多糖肠溶微丸及其制备方法
US11865099B2 (en) 2015-07-17 2024-01-09 Laboratori Baldacci S.P.A. Product based on iron bis-glycinate chelate and alginic acid and/or water-soluble salts thereof, formulations thereof, and pharmaceutical uses thereof
ITUB20152290A1 (it) * 2015-07-17 2017-01-17 Laboratori Baldacci Spa Prodotto a base di ferro bisglicinato chelato e acido alginico e/o suoi sali idrosolubili, sue formulazioni ed suoi usi farmaceutici
US20190038542A1 (en) * 2016-02-08 2019-02-07 Mirexus Biotechnologies Inc. Moisturizing personal care compositions comprising monodisperse phytoglycogen nanoparticles and a further polysaccharide

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3640741A (en) * 1970-02-24 1972-02-08 Hollister Inc Composition containing gel
DE2062715C3 (de) * 1970-12-19 1974-03-21 Efeka Friedrich & Kaufmann Arzneimittelfabrik, 3000 Hannover Verfahren zur Herstellung von oral applizierbaren Arzneimittelzubereitungen mit protrahierter Wirkstoffabgabe und Arzneimittelzubereitung
EP0188040B1 (en) * 1985-01-11 1991-08-14 Abbott Laboratories Limited Slow release solid preparation
JPS62178505A (ja) 1986-02-03 1987-08-05 Maruzen Kasei Kk 化粧料
JPS63290809A (ja) 1987-05-25 1988-11-28 Noebia:Kk 口唇用化粧料
CA2041774C (en) * 1990-11-27 1994-04-19 Mircea A. Mateescu Use of cross-linked amylose as a matrix for the slow release of biologically active compounds
IT1255488B (it) * 1992-08-04 1995-11-06 Angelini Francesco Ist Ricerca Polisaccaridi del glicogeno
US5705190A (en) * 1995-12-19 1998-01-06 Abbott Laboratories Controlled release formulation for poorly soluble basic drugs
US5807575A (en) 1997-02-14 1998-09-15 Rougier Inc. Manufacture of cross-linked amylose useful as a excipient for control release of active compounds
IT1298758B1 (it) 1998-03-19 2000-02-02 Angelini Ricerche Spa Soluzione umettante e lubrificante per uso oftalmico
US6607748B1 (en) * 2000-06-29 2003-08-19 Vincent Lenaerts Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
AU2001227030A1 (en) * 2000-11-22 2002-06-03 Lupin Laboratories Limited Pharmaceutical composition for controlled release of an active ingredient
CA2523246C (en) * 2003-04-25 2009-12-01 Kos Life Sciences, Inc. Formation of strong superporous hydrogels
US20060067917A1 (en) * 2004-09-20 2006-03-30 Athanassios Sambanis Insulin delivery system
WO2007047997A2 (en) 2005-10-19 2007-04-26 Smartcells, Inc. Methods for reducing the mitogenicity of lectin compositions

Also Published As

Publication number Publication date
AU2008342571A1 (en) 2009-07-09
EA018975B1 (ru) 2013-12-30
ATE518530T1 (de) 2011-08-15
US20100255083A1 (en) 2010-10-07
AU2008342571B2 (en) 2014-03-13
IL206124A (en) 2013-01-31
CA2708400A1 (en) 2009-07-09
SI2234607T1 (sl) 2011-11-30
GEP20125636B (en) 2012-09-10
ES2369868T3 (es) 2011-12-07
EA201070806A1 (ru) 2010-12-30
WO2009083561A1 (en) 2009-07-09
BRPI0821454A2 (pt) 2015-06-16
CN101909608A (zh) 2010-12-08
KR101561571B1 (ko) 2015-10-19
US8840923B2 (en) 2014-09-23
IL206124A0 (en) 2010-11-30
PT2234607E (pt) 2011-09-30
EP2234607A1 (en) 2010-10-06
UA98684C2 (uk) 2012-06-11
CA2708400C (en) 2016-02-02
DK2234607T3 (da) 2011-11-21
AR069960A1 (es) 2010-03-03
KR20100099728A (ko) 2010-09-13
JP2011519820A (ja) 2011-07-14
EP2234607B1 (en) 2011-08-03
HK1145284A1 (en) 2011-04-15
BRPI0821454B1 (pt) 2020-01-28
BRPI0821454B8 (pt) 2021-05-25
JP5416716B2 (ja) 2014-02-12
CN101909608B (zh) 2013-01-23

Similar Documents

Publication Publication Date Title
HK1145284A1 (en) A slow-release formulation based on an association of glycogen and alginate
EP2043952A4 (en) MIXTURES OF FULLERENE DERIVATIVES AND THEIR USES IN ELECTRONIC DEVICES
GB2492703B (en) Bootstrapper and software download manager
GB2450669B (en) Tantalam powder and methods of manufacturing same
IL198146A0 (en) Compositions and devices comprising silicone and specific polyphosphazenes
IL194733A0 (en) Photodisinfection delivery devices and methods
HK1131094A1 (en) Nanoparticles, methods of making, and applications using same
EP2177557A4 (en) LASER FRITTABLE POWDER AND SHAPED PRODUCT THEREOF
EP2054063A4 (en) 4-AMINOCHINAZOLINE DERIVATIVES AND METHOD FOR THEIR USE
ZA200903876B (en) Dental attachment assemly and method
EP2006284A4 (en) DICYCLOOCTANE DERIVATIVES, METHOD OF MANUFACTURE AND MEDICAL APPLICATIONS THEREOF
ZA200807544B (en) Pseudoinfectious flavivirus and uses thereof
IL194751A0 (en) Drugs and uses
EP2021261A4 (en) TRANSPORT UNIT AND METHOD FOR MANUFACTURING THE SAME
EP1997777A4 (en) SILICON DIOXIDE POWDER AND ITS USE
IL210683A0 (en) Modified release formulation and methods of use
EG25788A (en) Artificial teethridge and fang
ZA200705774B (en) Osteotome and components thereof
WO2009091274A9 (en) Appliance and procedure designed for the improvement of plant-production in the specially protected environment
TWI369233B (en) Game system and server
GB0613288D0 (en) Preservation and controlled delivery/release of spermatoza
HK1136303A1 (en) Formulation and use of ergosta-7,22-dien-3-ol -722--3-
IL192552A0 (en) Dnt-succinate and methods of preparation thereof
ZA200902942B (en) Combination of IAP Inhibitors and FLT3 Inhibitors
GB0807550D0 (en) Remote use of computer games and software applications